Table 1 Baseline characteristics of enrolled patients
N=300 | |
|---|---|
Age (years) | 61.98 ± 10.43 |
Range | 44-78 |
Sex | |
Male | 228 (76%) |
Female | 72 (24%) |
BMI (kg/m2) | 28.11 ± 7.60 |
Occupation | |
Employee | 249 (83%) |
Unemployed | 51 (17%) |
Comorbidities | |
Diabetes mellitus | 114 (38%) |
Hypertension | 84 (28%) |
Smoking status | |
Current smoker | 105 (35%) |
Ex-smoker | 114 (38%) |
Passive smoker | 72 (24%) |
Stopped smoking | 9 (3%) |
Type of smoking | |
Cigarette | 147 (49%) |
Shisha | 51 (17%) |
Both | 30 (10%) |
Smoking index | |
Mild | 6 (2%) |
Moderate | 9 (3%) |
Heavy | 213 (71%) |
COPD staging | |
I | 3 (1%) |
II | 36 (12%) |
III | 129 (43%) |
IV | 132 (44%) |
Number of exacerbation (year) | 3 (1-10) |
Number of hospitalization (year) | 2 (0-7) |
Current therapy | |
*Short-acting beta agonist | 99 (33%) |
*Long-acting beta agonist | 177 (59%) |
*Short-acting muscarinic antagonist | 24 (8%) |
*Long-acting muscarinic antagonist | 42 (14%) |
*Inhaled corticosteroid | 198 (66%) |
*Methylxanthines | 177 (59%) |
*No therapy | 12 (4%) |
Route of therapy | |
Oral | 21 (7%) |
Inhalational | 51 (17%) |
Both | 216 (72%) |
Compliant to prescribed therapy | 159 (53%) |
mMRC | |
1 | 6 (2%) |
2 | 84 (28%) |
3 | 192 (64%) |
4 | 18 (6%) |